Dr. Scott N. Gettinger

Claim this profile

Yale University

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
22 drugs studied

Area of expertise

1Lung Cancer
Scott N. Gettinger has run 3 trials for Lung Cancer. Some of their research focus areas include:
Stage III
Stage IV
PD-L1 negative
2Non-Small Cell Lung Cancer
Scott N. Gettinger has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage III
Stage IV
PD-L1 negative

Affiliated Hospitals

Image of trial facility.
Yale University
Image of trial facility.
Yale University- Yale Cancer Center

Clinical Trials Scott N. Gettinger is currently running

Image of trial facility.

NC318 + Pembrolizumab

for Lung Cancer

This trial is testing a new drug, NC318, alone or with Pembrolizumab, in patients with advanced lung cancer. It aims to help those who haven't responded to other treatments or have specific tumor characteristics. The drugs work by enhancing the immune system's ability to attack cancer cells.
Recruiting1 award Phase 28 criteria

More about Scott N. Gettinger

Clinical Trial Related9 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Scott N. Gettinger has experience with
  • NC318
  • Pembrolizumab
  • CAN-2409
  • Afatinib
  • Binimetinib
  • Capivasertib
Breakdown of trials Scott N. Gettinger has run
Lung Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Prostate Cancer
Bladder Cancer

Other Doctors you might be interested in

James Farrell, MDSmilow Cancer Hospital Care Center - Guiford
James Farrell, MDYale University
Nikolai A. PodoltsevYale University

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott N. Gettinger specialize in?
Scott N. Gettinger focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Scott N. Gettinger currently recruiting for clinical trials?
Yes, Scott N. Gettinger is currently recruiting for 1 clinical trial in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Scott N. Gettinger has studied deeply?
Yes, Scott N. Gettinger has studied treatments such as NC318, Pembrolizumab, CAN-2409.
What is the best way to schedule an appointment with Scott N. Gettinger?
Apply for one of the trials that Scott N. Gettinger is conducting.
What is the office address of Scott N. Gettinger?
The office of Scott N. Gettinger is located at: Yale University, New Haven, Connecticut 06492 United States. This is the address for their practice at the Yale University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top